Skip to content
The Policy VaultThe Policy Vault

Balversa (erdafitinib tablets – Janssen) — Cigna

Non-Small Cell Lung Cancer

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has metastatic disease
  • Patient has fibroblast growth factor receptor (FGFR) alterations

Approval duration

1 year